CHRISTINE CRISOSTOMO: Open Payments
NPI 1831739226 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$795 in 8 payments from 8 companies in 2025. Trend: 2023 $1,200 · 2024 $119 · 2025 $795
Food & beverage: $795
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $139 |
| Regeneron Healthcare Solutions, Inc. | 1 | $130 |
| ABIOMED | 1 | $127 |
| UCB, Inc. | 1 | $125 |
| Amarin Pharma, Inc. | 1 | $96 |
| PFIZER INC. | 1 | $83 |
| Eisai Inc. | 1 | $80 |
| ABBVIE INC. | 1 | $15 |
Products named: INFINITY, DUPIXENT, Rystiggo, Vascepa, ZAVZPRET, Leqembi, CREON.
Industry payments across CA — which companies pay providers there.
